Skip to main content

Advertisement

Log in

Can diffusion-weighted MRI improve response assessment of neo-adjuvant therapy in pancreatic cancer?

  • Commentary
  • Published:
European Radiology Aims and scope Submit manuscript

The Original Article was published on 01 November 2023

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Mizrahi JD, Surana R, Valle JW, Shrof RT (2020) Pancreatic cancer. Lancet 395(10242):2008–2020. https://doi.org/10.1016/S0140-6736(20)30974-0

    Article  CAS  PubMed  Google Scholar 

  2. Gillen S, Schuster T, Büschenfelde CM Zum et al (2010) Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages. PLoS Med 7. https://doi.org/10.1371/JOURNAL.PMED.1000267

  3. Porrello G (2023) Can a CT-based nomogram predict recurrence in resectable pancreatic body and tail adenocarcinoma? Eur Radiol 33(11):7779–7781. https://doi.org/10.1007/s00330-023-10193-2

    Article  PubMed  Google Scholar 

  4. Zins M, Matos C, Cassinotto C (2018) Pancreatic adenocarcinoma staging in the era of preoperative chemotherapy and radiation therapy. Radiology 287(2):374–390. https://doi.org/10.1148/radiol.2018171670

    Article  PubMed  Google Scholar 

  5. Barral M, Taouli B, Guiu B et al (2015) Diffusion-weighted MR imaging of the pancreas: current status and recommendations. Radiology 274:45–63. https://doi.org/10.1148/radiol.14130778

    Article  PubMed  Google Scholar 

  6. Morone M, Bali MA, Tunariu N et al (2017) Whole-body MRI: current applications in oncology. AJR Am J Roentgenol 209:W336–W349. https://doi.org/10.2214/AJR.17.17984

    Article  PubMed  Google Scholar 

  7. Bilreiro C, Andrade L, Marques RM, Matos C (2023) Diffusion-weighted imaging for determining response to neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis. Eur Radiol 1. https://doi.org/10.1007/s00330-023-10381-0.

Download references

Funding

The author states that this work has not received any funding.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vincent Vandecaveye.

Ethics declarations

Guarantor

The scientific guarantor of this publication is Vincent Vandecaveye.

Conflict of interest

The author of this manuscript declares no relationships with any companies, whose products or services may be related to the subject matter of the article.

Statistics and biometry

No complex statistical methods were necessary for this paper.

Informed consent

Written informed consent was not required for this study because this is a commentary.

Ethical approval

Institutional Review Board approval was not required because this is a commentary.

Study subjects or cohorts overlap

Not applicable.

Methodology

• commentary

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This comment refers to the article available at https://doi.org/10.1007/s00330-023-10381-0.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vandecaveye, V. Can diffusion-weighted MRI improve response assessment of neo-adjuvant therapy in pancreatic cancer?. Eur Radiol (2023). https://doi.org/10.1007/s00330-023-10528-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00330-023-10528-z

Navigation